9:04 AM ET
8-K
Leadership Change
Arcutis Biotherapeutics Leadership Change
Arcutis Biotherapeutics appointed Dr. Robert Scott to its Board of Directors and the Nominating and Corporate Governance Committee, effective October 23, 2026. Dr. Scott, a former Chief Medical Officer at AbbVie and Amgen, joins as a Class II director with a term expiring in 2028. As part of his appointment, he received an initial stock option award for 20,507 shares of common stock.